Sidebar
Drug Approval Process
DTC Marketing

Dominoes from FDA advisory panel on Amgen's Denosumab starting to fall?

Aug/19/2009 10:20 Filed in: FDA
images
It looks like drug companies got the message the FDA was sending when an advisory panel took a precautionary look at Amgen’s Denosumab. Just this week at least 3 new products in clinical trials were halted when the products “failed to meet end points”. Read More...

Tags:

|